May 12, 2015
Sumitomo Dainippon President Masayo Tada Sumitomo Dainippon Pharma suffered from steep profit declines in FY2014, hobbled by NHI drug price revisions in April last year and rapid generic erosions stemming from newly launched government incentives. The Japanese drug major reported...read more